SMTI Earnings Sanara MedTech Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–46 of 46
| Q2 2026 | 2026-06-30 | -0.05 | 2026-08-11 | 10-Q |
| Q1 2026 | 2026-03-31 | 0.05 | 2026-05-12 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | -0.32 | 2026-03-24 | 10-K |
| FY 2025 | 2025-12-31 | -4.36 | 2026-03-24 | 10-K |
| Q3 2025 | 2025-09-30 | -3.40 | 2025-11-12 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.23 | 2025-08-13 | 10-Q |
| Q1 2025 | 2025-03-31 | -0.41 | 2025-05-14 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | -0.18 | 2025-03-25 | 10-K |
| FY 2024 | 2024-12-31 | -1.14 | 2025-03-25 | 10-K |
| Q3 2024 | 2024-09-30 | -0.34 | 2024-11-12 | 10-Q |
| Q2 2024 | 2024-06-30 | -0.41 | 2024-08-12 | 10-Q |
| Q1 2024 | 2024-03-31 | -0.21 | 2024-05-13 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | -0.03 | 2024-03-25 | 10-K |
| FY 2023 | 2023-12-31 | -0.52 | 2024-03-25 | 10-K |
| Q3 2023 | 2023-09-30 | -0.13 | 2023-11-13 | 10-Q |
| Q2 2023 | 2023-06-30 | -0.22 | 2023-08-14 | 10-Q |
| Q1 2023 | 2023-03-31 | -0.14 | — | — |
| FY 2022 | 2022-12-31 | -1.00 | — | — |
| Q3 2022 | 2022-09-30 | -0.18 | — | — |
| Q3 2022 | 2022-06-30 | 0.09 | 2022-11-14 | 10-Q |
| Q4 2020 (derived) | 2020-12-31 | -0.01 | 2021-03-30 | 10-K |
| FY 2020 | 2020-12-31 | -0.76 | 2021-03-30 | 10-K |
| Q3 2020 | 2020-09-30 | -0.18 | 2020-11-13 | 10-Q |
| Q2 2020 | 2020-06-30 | -0.18 | 2020-08-13 | 10-Q |
| Q1 2020 | 2020-03-31 | -0.39 | 2020-05-12 | 10-Q |
| Q4 2019 (derived) | 2019-12-31 | -0.43 | — | — |
| FY 2019 | 2019-12-31 | -1.32 | — | — |
| Q3 2019 | 2019-09-30 | -0.35 | — | — |
| Q2 2019 | 2019-06-30 | -0.15 | 2019-08-14 | 10-Q |
| Q1 2019 | 2019-03-31 | -0.39 | 2019-05-20 | 10-Q |
| Q4 2018 (derived) | 2018-12-31 | 0.07 | 2019-04-01 | 10-K |
| FY 2018 | 2018-12-31 | 0.00 | 2019-04-01 | 10-K |
| Q3 2018 | 2018-09-30 | 0.00 | 2018-11-14 | 10-Q |
| Q2 2018 | 2018-06-30 | 0.01 | 2018-08-13 | 10-Q |
| Q1 2018 | 2018-03-31 | -0.08 | 2018-05-15 | 10-Q |
| Q4 2017 (derived) | 2017-12-31 | 0.00 | 2018-03-29 | 10-K |
| FY 2017 | 2017-12-31 | 0.00 | 2018-03-29 | 10-K |
| Q3 2017 | 2017-09-30 | 0.00 | 2017-11-16 | 10-Q |
| Q2 2017 | 2017-06-30 | 0.00 | 2017-08-14 | 10-Q |
| Q1 2017 | 2017-03-31 | 0.00 | 2017-05-15 | 10-Q |
| Q4 2016 (derived) | 2016-12-31 | 0.00 | — | — |
| FY 2016 | 2016-12-31 | -0.01 | — | — |
| Q3 2016 | 2016-09-30 | 0.00 | 2016-11-10 | 10-Q |
| Q2 2016 | 2016-06-30 | -0.01 | — | — |
| Q1 2016 | 2016-03-31 | 0.00 | — | — |
| Q3 2015 | 2015-09-30 | 0.00 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.